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WORK I N  PROGRESS 
occasion. We  now feel that we should abide by the same rules as apply 
for transfusions: that 0 to A is probably safe but that A to 0 is not safe. 
In two instances where this kind of mismatch was attempted, the 
implanted kidney failed to "pink-up," and after several hours' ob- 
servation it was removed. In  a third, the kidney immediately functioned 
well, but after 24 hours renal function diminished markedly. Now, over 
two months later, the kidney is functioning fairly well, but definitely 
less well than other experience would lead us to expect. Whether this 
doubtful result is related to the blood-group poblem or to the under- 
lying disease I shall hscuss later. 
Examination of the kidneys which failed to gain adequate circula- 
tion under observation showed grossly a very pale cortex. After at- 
tempted perfusion with radiopaque material, X-ray study in one 
showed filling of only the larger vessels. Microscopic examination 
showed hemagglutination in the small vessels. Presumably the small 
vessels never did open up. 
To discuss the technical aspects a little: when we were using mis- 
matched blood, we perfused the kidney with buffer at 15OC and pro- 
caine, in an effort to prevent vascular spasm. When we were using 
donors in whom the matching was satisfactory, we cooled the donor so 
that we started with a cooled organ. At the time of operation, one 
expects urine flow to begin immediately; within 5 to 90 minutes, I 
think, has been the time when the urine flow does begin. It is very 
rapid-up to 500 ml per hour for 12 to 18 hours. 
The time of ischemia in the transplants has varied from as short as 
17 minutes to as high as 81 minutes, with a mean of 33 minutes. The 
longer the ischemia, the less likely the transplant seems to take. The 
third instance in which a second implant had to be used was one in 
which technical difficulties prolonged the ischemia to the maximum 
noted above. 
As far as the methods of trying to control rejection are concerned, 
at first, as you probably know, we were doing thymectornies, but this 
proved to be so difficult from the surgical point of view that we have 
given that up now; there were several cases where uncontrollable oozing 
and infection at the site of the wound took place. 
Splenectomy is being done routinely as a means of removing excess 
lymphocytes; nephrectomy is being done routinely. Usually, the 
s~)lenectomies are done a t  the same time as the transplant, so only one 
operative procedure is involved. 
The type of immuno-suppressive therapy that we have been using 
has, in general, been limited to drugs. In  the first case, we did use total 
body irradiation, but since that time we have been using drugs only. 
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These drugs consist of azothioprine, or Imurana, which is started 10 to 
12 days before the operation, and then steroids as well as actinomycin 
C are given in large doses when signs of rejection occur. 
Figure 88 presents a chart of the first patient, who had everything: 
a thymectomy, indicated by T; a bilateral nephrectomy and splenectomy 
(BLNS); he was being dialyzed all this time (D) pre~perat ivel~,  and 
he was given X-irradiation before the operation and again after the 
operation. Finally, he was given azothioprine, or Imuran, subsequent 
to operation, and steroids in large doses. 
One interesting point, that does not show here, is the diuresis that 
occurs immediately after operation. At the time of his rejection crisis, 
he had a marked drop in  clearance of creatinine, in spite of the fact 
that he had an extremely low blood count, presumably due to total 
body irradiation. 
The average diuresis in 25 cases has been of the order of 450 ml 
per hour in the first 12 hours, so that you can see that keeping up with 
the fluid balance can be a difficult thing. 
The signs of rejection occurred with the rising BUN, the rising 
temperature, and the drop in his creatinine clearance. He  was im- 
mediately treated with steroids and actinomycin C. The rejection 
apparently reversed itself, his creatinine clearance improved, and he 
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FIGURE 88. Graphic representation of early course on one patient, a 12-year-old boy 
whose mother was the donor. (Permission received from A.M.A.) 
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DR. LEWIS: NO. 
DR. LANGE: Could YOU tell US whether all the patients are still on the 
immuno-suppressive therapy and how long you continue them on such 
therapy and with what dose? Do you think this so-called "toxicity" may 
be something similar to homologous or runt disease? 
DR. RILEY: That is what it looks like, but I do not know the answer 
to that question, as far as the runt disease goes. Our longest patient, 
who is now rounding out eleven months, has been taken off steroids, 
but is still getting relatively small doses of Imuran. Imuran, as you 
know, is very sinular to 6-mer~apto~urir~e, and our dose, as a starter, 
has usually been around 2.5 to 3 mg/Kg. It is being tapered at the 
moment. 
DR. CLARK: I would be interested in knowing about three things. First, 
in regard to infection, while these patients are on immuno-suppressive 
therapy, one can have a transplant, as we have had, at 68 days, that 
died of a spirillosis. We have been concerned about this, giving 
antibiotic therapy or germ-free living and so on. 
Secondly, have you been paying a great deal of attention to the 
urine sediment in, perhaps, early rejecrion that is-whether it may be a 
clue? 
Lastly, could you comment on the histologic findings in the trans- 
planted kidney of those who have died? 
DR. RILEY: First, about the infection: we have put the recipients into 
a "germ-free environment" which is fairly complete, with gloves and 
masks, etc. We have not routinely put them on antibiotics. We treat 
when signs of infection occur. In those who did not have signs of in- 
fection prior to operation, we have had pretty good luck. Some of those 
in the early stages had infected wounds or some other cause beforehand, 
and those did not take to this treatment very well. It is quite alarming 
to see the white count go down to 300 or even less. 
We have not looked at the urinary sediment, and I am not well 
enough informed to discuss the histology in detail. In general, I am told 
that the kidneys have looked essentially normal, and that the deaths 
have been from causes apparently unrelated to the kidney. 
DR. ELKINTON: Have you given up all consideration of the cadavar as 
the source of kidneys? 
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1 pneumothorax, unexplained. But, other than those, there have been no complications among the donors. The two kidneys that came from 
cadavers were so long in getting from the donor when alive into the 
recipient that they never did work, and there is a very strong feeling 
' among our surgeons that the time of ischemia is extremely important. 
I If you could get a prospective cadaver to agree to a llving removal, I 
1 thlnk that this could be possible. But, what with getting family per- 
niission and removing the kidney, the time interval is so great that our 
men are not doing it. 
CIIAIHMAN BAHNETT: Didn't Dr. Merrill sdy that they have some 
I survivals with cadaver kidneys? 
DR. RILEY: Yes; one, a long-time survivor, too. 
I 
' DR. ELKINTON: The time of ischemia did not exceed 71 to 81 minutes 
in your cadaver kidney transplants. Ours was two hours and did quite I 
well. 
DR. RILEY: The two that we have done, taking 71 and 81 minutes, were 
from living donors, and never functioned. I do not know the exact time 
of the ischemia of the cadaver transplants. It was, however, in the 2- 
hour range. 
DR. BERNSTEIN: Dr. Riley, was there any relation between the ' pathologic disease and the Lidneys of the recipient? 
I DR. RILEY: I do not think there has been. For the most part, we do not 
try to be too accurate in the diagnosh-we call it "terminal renal 
failure." 
DR. LANGE: Did you have any incidence of lupus in your surviving 
cases? After giving massive therapy to lupus cases for long periods of 
time, I have seen many flareups. I wonder whether this is just specific 
to lupus erythematosus, or whether it represents the result of pro- 
1 longed steroid therapy. 
DR. RILEY: We have not seen any. It may be the short duration of 
time. 
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DR. MANN: We have a rather perplexing I)roblem that just came u p  
We perfornied a transplant in apparently identical twiiis. About four 
months later, the recipient developed serum hepatitis. About two weeks 
later, he developed apparent rejection of the kidney, and succumbed. 
The pathology demonstrated the typical rejection reaction. We are 
wondering whether anyone has experienced any similar problem? 
DR. RILEY: No, I have not. 
CHAIRMAN BARNETT: Thank you, Dr. Riley. The last talk is by Dr. 
Paul Kirnmelstiel. 
"Sterile Pyelonephritis" 
and "PPLO" 
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L I E N - H W A  H O  
Last year I reported to you a few pilot experiments in which we found 
PPLO in tissues of rat kidneys with "sterile pyelonephritis." It took me 
all year to come to the conclusion that my statement then was probably 
correct. During the past year we worked with rat kidneys, which, one 
month after ligation of the ureter, showed hydr~ne~hrosis  and chronic, 
partially purulent pyelonel)hritis. At no time during the three months' 
duration of the experiments could organisms be cultured with con- 
ventional methods. 
Sterile tissue emulsion was streaked on one-half of a commercial 
PPLO agar plate. The controlled side and streaks of normal rat kidney 
from the contralateral side always showed occasional colonies of similar 
type. The diseased kidney emulsions, however, showed between 10 and 
50 times more colonies. This may indicate (1) that horse serum 
normally contains PPLO and that there is a factor (enzyme) in the 
kidney that accelerates its growth; or (2) that it merely forms arti- 
factual structures from substances in the agar; or ( 3 )  that there really 
is an increased number of such organisms in the diseased kidney in 
which they normally occur in small numbers. 
The type of colony we obtained on appropriate media has long been 
regarded as an artifact. It was identified as a soap crystal and later, in 
1940, by Brown as a 'Lpseudocolony." It has not been heard from since. 
Because we found these "pseudocolonies" in such large numbers in 
diseased kidneys, in contrast to the contralateral normal kidney, we 
studied these colonies in detail and found: 
1. A battery of stains revealed that the colonies are much like classic 
PPLO and most probably contain RNA since acridine orange fluo- 
rescence was inhibited by specific ribonuclease. Characteristically, these 
colonies grow in a swirl-like pattern. 
